OverviewSuggest Edit

Luye Pharma Group (绿叶制药) is a pharmaceutical company that develops, manufactures, and sells medications. It offers a range of products covering central nervous system, oncology, and other therapeutic areas. In addition, the company focuses on technologies such as microspheres, liposomes, and transdermal drug delivery systems to develop biological antibodies, cell and gene therapies.

Latest Updates

Employees (est.) (Dec 2018)4,417
Share Price (Aug 2020)$5.1
Cybersecurity ratingCMore

Luye Pharma Financials and Metrics

Luye Pharma Revenue

Market capitalization (5-Aug-2020)


Closing stock price (5-Aug-2020)

Luye Pharma's current market capitalization is $16.4 b.
Show all financial metrics

Luye Pharma Cybersecurity Score

Cybersecurity ratingPremium dataset



SecurityScorecard logo

Luye Pharma Online and Social Media Presence

Embed Graph

Luye Pharma News and Updates

La demande d'autorisation de mise sur le marché de Rivalif®, patch transdermique multijours à base de rivastigmine de Luye Pharma, est en cours d'examen par les autorités compétentes de l'UE

MISBACH, Allemagne, 21 mai 2020 /PRNewswire/ -- Luye Pharma Group a annoncé aujourd'hui que la demande d'autorisation de mise sur le marché (AMM) au sein du territoire européen de son patch transdermique multijours à base de rivastigmine (nom de marque : Rivalif®, code produit : LY30410),...

Luye Pharma Frequently Asked Questions

  • When was Luye Pharma founded?

    Luye Pharma was founded in 1994.

  • How many employees does Luye Pharma have?

    Luye Pharma has 4,417 employees.

  • Who are Luye Pharma competitors?

    Competitors of Luye Pharma include Alligator Bioscience, BlinkBio and Navigen.